Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.

Hermsen, CC; Verhage, DF; Telgt, DS; Teelen, K; Bousema, JT; Roestenberg, M; Bolad, A; Berzins, K; Corradin, G; Leroy, O; +2 more... Theisen, M; Sauerwein, RW; (2007) Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine, 25 (15). pp. 2930-40. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2006.06.081

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2006.06.081

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar